Century Therapeutics logo

Century Therapeutics Share Price Today

(NASDAQ: IPSC)

Century Therapeutics share price is $0.61 & ₹53.05 as on 6 Mar 2025, 2.30 'hrs' IST

$0.61

0.01

(0.83%)

Market is closed - opens 8 PM, 06 Mar 2025

View live Century Therapeutics share price in Dollar and Rupees. Guide to invest in Century Therapeutics stock from India, including Indian investor sentiment. Get details on Indian mutual funds investing in Century Therapeutics, along with analyst recommendations, forecasts, and comprehensive financials.

Century Therapeutics share price movements

  • Today's Low: $0.60
    Today's High: $0.65

    Day's Volatility :6.9%

  • 52 Weeks Low: $0.60
    52 Weeks High: $5.51

    52 Weeks Volatility :89.07%

Century Therapeutics (IPSC) Returns

PeriodCentury Therapeutics IncSector (Health Care)Index (Russel 2000)
3 Months
-57.69%
2.1%
0.0%
6 Months
-57.98%
-4.1%
0.0%
1 Year
-87.9%
2.2%
0.0%
3 Years
-95.62%
11.8%
-11.6%

Century Therapeutics (IPSC) Key Statistics

in dollars & INR

Previous Close
$0.6051
Open
$0.616
Today's High
$0.6478
Today's Low
$0.6031
Market Capitalization
$52.2M
Today's Volume
$143.3K
52 Week High
$5.51
52 Week Low
$0.6021
Revenue TTM
$2.7M
EBITDA
$-117.9M
Earnings Per Share (EPS)
$-1.83
Profit Margin
0.0%
Quarterly Earnings Growth YOY
0.0%
Return On Equity TTM
-62.61%

How to invest in Century Therapeutics Stock (IPSC) from India?

It is very easy for Indian residents to invest directly in Century Therapeutics from India. Indian investors can open a free US stocks account on the INDmoney app. You can find live prices of the Century Therapeutics stock in both Indian Rupees (INR) and US Dollars (USD). Search for Century Therapeutics or IPSC on the INDmoney app and click on Buy or SIP. You can invest by choosing quantities of shares of Century Therapeutics or rupee/ dollar value or set up a fixed SIP amount to be invested every month or week.

For example: You can easily buy Rs.100 worth of Century Therapeutics shares which would translate to 1.426 fractional shares of Century Therapeutics as of today. Learn more about fractional investing.

Indians can now also easily transfer and add money to their US stocks account via the INDmoney app. Invest in US Stocks from India, including recognised companies like Century Therapeutics, in just a few clicks!

Returns in Century Therapeutics (IPSC) for Indian investors in Rupees

The Century Therapeutics stock calculator helps Indian investors calculate returns based on the historical performance of the stock. Just choose your investment amount and duration to get insights and invest more confidently. See stock returns as well as the effect of dollar appreciation over different durations.

Investment Value

₹1,00,000

  • 1Y

  • 3Y

  • 5Y

  • 7Y

  • 10Y

Century Therapeutics investment value today

Current value as on today

₹17,163

Returns

₹82,837

(-82.84%)

Returns from Century Therapeutics Stock

₹87,800 (-87.8%)

Dollar Returns

₹4,963 (+4.96%)

Indian investors sentiment towards Century Therapeutics (IPSC)

-31%

Period: Feb 3, 2025 to Mar 5, 2025. Change in 30 Days versus previous period

Search interest for Century Therapeutics Stock from India on INDmoney has decreased by -31% in the last 30 days, reflecting a downward trend in search activity.

Global Institutional Holdings in Century Therapeutics

  • Bain Capital Life Sciences Investors, LLC

    6.36%

  • Casdin Capital, LLC

    6.10%

  • VR Adviser, LLC

    4.65%

  • Boxer Capital LLC

    4.59%

  • BlackRock Inc

    3.57%

  • FMR Inc

    2.98%

Analyst Recommendation on Century Therapeutics

Buy

    84%Buy

    15%Hold

    0%Sell

Based on 13 Wall street analysts offering stock ratings for Century Therapeutics(by analysts ranked 0 to 5 stars)

Based on 13 analyst
  • Current
  • 1M Ago
  • 3M Ago
Buy
11
11
11
Hold
2
2
2
Sell
0
0
0

Analyst Forecast on Century Therapeutics Stock (IPSC)

What analysts predicted

Upside of 1375.41%

Target:

$9.00

Current:

$0.61

Insights on Century Therapeutics Stock (Ticker Symbol: IPSC)

  • Price Movement

    In the last 3 months, IPSC stock has moved down by -57.7%
  • Increasing Revenue

    Revenue is up for the last 2 quarters, 771.0K → 791.0K (in $), with an average increase of 2.5% per quarter
  • Decreasing Net Profit

    Netprofit is down for the last 3 quarters, -28.06M → -31.22M (in $), with an average decrease of 5.6% per quarter
  • IPSC vs ALNY (1 yr)

    In the last 1 year, Alnylam Pharmaceuticals, Inc. has given 62.3% return, outperforming this stock by 148.1%
  • IPSC vs VRTX (3 yr)

    In the last 3 years, Vertex Pharmaceuticals Incorporated has given 47.7% return, outperforming this stock by 143.2%
  • Price to Sales

    ForIPSC every $1 of sales, investors are willing to pay $16.4, whereas for Alnylam Pharmaceuticals, Inc., the investors are paying $13.8 for every $1 of sales.

Century Therapeutics Technicals Summary

Sell

Neutral

Buy

Century Therapeutics is currently not in a favorable trading position ( SELL ) according to technical analysis indicators.

Century Therapeutics (IPSC) Vs Peers

Company Name1 Month6 Month1 Year3 Years5 Years
Century Therapeutics Inc logo
-22.43%
-57.98%
-87.9%
-95.62%
-97.81%
Regeneron Pharmaceuticals, Inc. logo
1.3%
-41.29%
-30.51%
9.2%
42.38%
Beone Medicines Ltd logo
15.19%
34.31%
61.3%
43.16%
68.1%
Vertex Pharmaceuticals Incorporated logo
3.37%
3.77%
18.06%
106.43%
121.36%
Alnylam Pharmaceuticals, Inc. logo
-11.52%
-3.4%
62.32%
49.04%
120.93%
Company NameP/E RatioP/B RatioPEG RatioEPSROEROADiv YieldBVPS
Century Therapeutics Inc logo
45.5
NA
NA
-1.62
-0.63
-0.21
NA
2.31
Regeneron Pharmaceuticals, Inc. logo
17.85
17.85
1.03
43.09
0.16
0.07
0.01
273.57
Beone Medicines Ltd logo
NA
NA
NA
1.43
-0.19
-0.06
NA
31.22
Vertex Pharmaceuticals Incorporated logo
32.84
NA
1.33
18.07
-0.03
0.13
NA
63.87
Alnylam Pharmaceuticals, Inc. logo
NA
NA
-0.49
0.57
-15.01
-0.03
NA
0.52
Company NameAnalyst ViewMarket Cap5 Years Return %PE RatioProfit Margin
Century Therapeutics Inc logo
Buy
$52.2M
-97.81%
45.5
0.0%
Regeneron Pharmaceuticals, Inc. logo
Buy
$74.9B
42.38%
17.85
31.07%
Beone Medicines Ltd logo
NA
$28.5B
68.1%
NA
-16.92%
Vertex Pharmaceuticals Incorporated logo
Buy
$124.1B
121.36%
32.84
-4.86%
Alnylam Pharmaceuticals, Inc. logo
Buy
$31.5B
120.93%
NA
-12.37%

About Century Therapeutics

Century Therapeutics, Inc., a biotechnology company, engages in the development of genetically engineered allogeneic cell therapies for the treatment of solid tumor and hematological malignancies. Its lead product candidate is CNTY-101, an allogeneic, induced pluripotent stem cells (iPSCs)-derived chimeric antigen receptors (CAR)-iNK cell therapy, under Phase 1 trials targeting CD19 for relapsed, refractory B-cell lymphoma. The company is also involved in the development of CNTY-102, a bi-specific CD19 + CD22 CAR-iT product candidate for relapsed, refractory B-cell lymphoma and other B-cell malignancies; and CNTY-107, a Nectin-4 CAR-iT targeted product candidate for Nectin-4 positive solid tumors. In addition, it has a strategic collaboration with Bristol-Myers Squibb Company to develop and commercialize up to four iNK or iT programs, including CNTY-104, a multi-specific collaboration program targeting acute myeloid leukemia; and CNTY-106, a multi-specific collaboration program for multiple myeloma. The company was incorporated in 2018 and is headquartered in Philadelphia, Pennsylvania.
Organization
Century Therapeutics
Employees
152
CEO
Mr. Brent Pfeiffenberger M.B.A., Pharm.D.
Industry
Non-Energy Minerals

Management People of Century Therapeutics

NameTitle
Mr. Brent Pfeiffenberger M.B.A., Pharm.D.
CEO & Director
Dr. Adrienne Farid Ph.D.
Chief Development Officer, CCO & Head of Early Development
Dr. Gregory Russotti Ph.D.
Chief Technology & Manufacturing Officer
Dr. Morgan Conn Ph.D.
Chief Financial Officer
Dr. Chad A. Cowan Ph.D.
Chief Scientific Officer
Dr. Shane Williams Ph.D.
Chief People Officer
Michael Naso Ph.D.
Senior VP of Cell Engineering
Dr. Nick Trede M.D., Ph.D.
Senior VP & Head of Clinical Development
Ms. Katja Buhrer
SVP, Head of Corporate Affairs & Strategy
Mr. Douglas Carr CPA
Senior VP of Finance & Operations and Secretary

Important FAQs about investing in IPSC Stock from India :

What is Century Therapeutics share price today?

Century Therapeutics share price today stands at $0.61, Open: $0.62 ; Previous Close: $0.61 ; High: $0.65 ; Low: $0.60 ; 52 Week High: $5.51 ; 52 Week Low: $0.60.

The stock opens at $0.62, after a previous close of $0.61. The stock reached a daily high of $0.65 and a low of $0.60, with a 52-week high of $5.51 and a 52-week low of $0.60.

Can Indians buy Century Therapeutics shares?

Yes, Indians can invest in the Century Therapeutics (IPSC) from India.

With INDmoney, you can buy Century Therapeutics at 0 brokerage. The step-by-step process is as follows:

  • Open your zero cost US Stocks account and zero balance IND linked savings a/c (this can be done in less than 3 minutes)
  • Transfer funds to your US Stocks account using your IND linked savings a/c (It takes 24 hours excluding Saturday and Sunday). With INDmoney, you get the best INR USD exchange rates.
  • Once funds are transferred successfully, you can buy Century Therapeutics at zero transaction cost.

How can I buy Century Therapeutics shares from India?

It is very easy to buy Century Therapeutics from India. With INDmoney, you can open a US stocks account in less than 3 minutes. Transfer funds in 24 hours and buy stocks very easily - that too at 0 brokerage. All this is done at 0 account opening & management fee, 0 brokerages, and at the same time you get the best rupee-US dollar exchange rate.

Can Fractional shares of Century Therapeutics (IPSC) be purchased?

Yes, you can buy fractional shares of Century Therapeutics with INDmoney app.

What are the documents required to start investing in Century Therapeutics stocks?

To start investing in Century Therapeutics, You will need the following documents:

  • Proof of Identification (PAN, Aadhaar etc)
  • Proof of address (Aadhaar, Voter ID etc)

These documents are required as per RBI's guidelines to create your IND linked savings a/c so that you can execute for global fund transfer. The entire process is paperless and can be completed seamlessly.

What are today’s High and Low prices of Century Therapeutics Stock (IPSC)?

Today’s highest price of Century Therapeutics (IPSC) is $0.65.

Today’s lowest price of Century Therapeutics (IPSC) is $0.60.

What is today's market capitalisation of Century Therapeutics?

Today's market capitalisation of Century Therapeutics IPSC is 52.2M

What is the 52 Week High and Low Range of Century Therapeutics Stock (IPSC)?

  • 52 Week High

    $5.51

  • 52 Week Low

    $0.60

What are the historical returns of Century Therapeutics (IPSC)?

  • 1 Month Returns

    -22.43%

  • 3 Months Returns

    -57.98%

  • 1 Year Returns

    -87.9%

  • 5 Years Returns

    -97.81%

Who is the Chief Executive Officer (CEO) of Century Therapeutics ?

Mr. Brent Pfeiffenberger M.B.A., Pharm.D. is the current Chief Executive Officer (CEO) of Century Therapeutics.